American Association for Cancer Research
Browse

Supplementary Table S2 from Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors

Download (79.08 kB)
journal contribution
posted on 2023-03-31, 23:17 authored by Petra Ross-Macdonald, Heshani de Silva, Qi Guo, Hong Xiao, Chen-Yi Hung, Becky Penhallow, Jay Markwalder, Liqi He, Ricardo M. Attar, Tai-an Lin, Steven Seitz, Charles Tilford, Judith Wardwell-Swanson, Donald Jackson
Supplementary Table S2 from Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors

History

ARTICLE ABSTRACT

In developing inhibitors of the LIM kinases, the initial lead molecules combined potent target inhibition with potent cytotoxic activity. However, as subsequent compounds were evaluated, the cytotoxic activity separated from inhibition of LIM kinases. A rapid determination of the cytotoxic mechanism and its molecular target was enabled by integrating data from two robust core technologies. High-content assays and gene expression profiling both indicated an effect on microtubule stability. Although the cytotoxic compounds are still kinase inhibitors, and their structures did not predict tubulin as an obvious target, these results provided the impetus to test their effects on microtubule polymerization directly. Unexpectedly, we confirmed tubulin itself as a molecular target of the cytotoxic kinase inhibitor compounds. This general approach to mechanism of action questions could be extended to larger data sets of quantified phenotypic and gene expression data. [Mol Cancer Ther 2008;7(11):3490–8]

Usage metrics

    Molecular Cancer Therapeutics

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC